QuiremSpheres™ will be reimbursed in Belgium as of 1 October 2017

We are happy to announce that QuiremSpheres will be fully reimbursed in Belgium as of 1 October 2017.

Jan Sigger, CEO of Quirem Medical B.V., the manufacturer of QuiremSpheres™, said: “The decision of the Belgian authorities to fully reimburse QuiremSpheres™ is consistent with the fact that our product uses the same mode of action and the same radiotherapeutic principles to target liver cancer as existing products on the market. Additionally, we believe that usage of QuiremSpheres™ can further enhance treatment outcome by the unique possibility to visualize and quantify the intrahepatic dose distribution right after the SIRT procedure.”

More information can be found on the website of our strategic partner Terumo, which is the exclusive global distributor of QuiremSpheres.

Share this post

Necessary cookies help make a website more usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.


Statistical cookies help us understand how visitors use the website by collecting and reporting data anonymously. These cookies therefore do not collect any personal data from visitors.

Cookies are small text files that can be used by websites to make user experiences more efficient. By law, we may store cookies on your device if they are strictly necessary for the use of the website. These are the functional cookies. We need your consent for all other types of cookies. These cookies are named as: preferences and statistics and you do not have to accept them. This website uses different types of cookies. Some cookies are placed by third party services that are displayed on our pages.

This website uses cookies to improve your experience. You can manage your options here.